(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(0.40%) $78.42
(1.87%) $2.18
(0.10%) $2 310.80
(0.61%) $26.85
(0.01%) $965.35
(0.00%) $0.929
(-0.23%) $10.85
(-0.03%) $0.797
(0.52%) $91.61
4 days till quarter result
(bmo 2024-05-09)
Expected move: +/- 0.00%
0.00% ¥ 18.00
Live Chart Being Loaded With Signals
OncoTherapy Science, Inc. researches and develops anti-cancer medicines and therapies in Japan. Its clinical development product pipeline includes small-molecule drugs, such as OTS167, a maternal embryonic leucine zipper kinase inhibitor that is in Phase I/II clinical trials for the treatment of acute myeloid leukemia, as well as in Phase I clinical trials for the treatment of breast cancer; and OTS964, a T-LAK cell-originated protein kinase inhibitor for the treatment of various cancer diseases...
Stats | |
---|---|
Volumen de hoy | 2.54M |
Volumen promedio | 2.47M |
Capitalización de mercado | 4.03B |
EPS | ¥0 ( 2024-02-08 ) |
Próxima fecha de ganancias | ( ¥0 ) 2024-05-09 |
Last Dividend | ¥0 ( N/A ) |
Next Dividend | ¥0 ( N/A ) |
P/E | -3.13 |
ATR14 | ¥0.196 (1.15%) |
Volumen Correlación
OncoTherapy Science, Inc. Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
OncoTherapy Science, Inc. Correlación - Moneda/Commodity
OncoTherapy Science, Inc. Finanzas
Annual | 2022 |
Ingresos: | ¥1.13B |
Beneficio Bruto: | ¥41.69M (3.67 %) |
EPS: | ¥-5.81 |
FY | 2022 |
Ingresos: | ¥1.13B |
Beneficio Bruto: | ¥41.69M (3.67 %) |
EPS: | ¥-5.81 |
FY | 2022 |
Ingresos: | ¥1.15B |
Beneficio Bruto: | ¥113.91M (9.87 %) |
EPS: | ¥-13.72 |
FY | 2021 |
Ingresos: | ¥332.48M |
Beneficio Bruto: | ¥19.54M (5.88 %) |
EPS: | ¥-8.86 |
Financial Reports:
No articles found.
OncoTherapy Science, Inc.
OncoTherapy Science, Inc. researches and develops anti-cancer medicines and therapies in Japan. Its clinical development product pipeline includes small-molecule drugs, such as OTS167, a maternal embryonic leucine zipper kinase inhibitor that is in Phase I/II clinical trials for the treatment of acute myeloid leukemia, as well as in Phase I clinical trials for the treatment of breast cancer; and OTS964, a T-LAK cell-originated protein kinase inhibitor for the treatment of various cancer diseases. The company's clinical development product pipeline also comprise cancer- specific peptide vaccines, including S-588410, which is in Phase III clinical trials for the treatment esophageal cancer, as well as in Phase II clinical trials for the treatment of bladder cancer; S-488210 that is in Phase I/II clinical trials for the treatment of head and neck cancer; and S-588210, which is in Phase I clinical trials for the treatment of solid tumor. In addition, it is developing antibody drugs consisting of OTSA101, which is in Phase I clinical trials for synovial sarcoma; and KHK6640, an anti-amyloid beta peptide antibody that is Phase I clinical trials for Alzheimer's disease. Further, the company provides contract analysis services. OncoTherapy Science, Inc. was founded in 2001 and is headquartered in Kawasaki, Japan.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico